Appetite stimulants

Khiron Life Sciences Corp.: Invitation to the Q2 Virtual Investor Summit

Retrieved on: 
Wednesday, May 12, 2021

b'About Khiron Life Sciences Corp.\nKhiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America.

Key Points: 
  • b'About Khiron Life Sciences Corp.\nKhiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America.
  • Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products.
  • Its Wellbeing unit launched the first branded CBD skincare brand in Colombia, with KuidaTM now marketed in multiple jurisdictions in Latin America, the US and United Kingdom.
  • The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.\n'

Khiron Comments on the Results of Project Twenty21 - UK´s Largest Observational Study into Medical Cannabis Products

Retrieved on: 
Tuesday, May 11, 2021

"\nTejinder Virk, President of Khiron Europe, says: "We are glad to see our strong commitment with medical research bear its fruits with this publication.

Key Points: 
  • "\nTejinder Virk, President of Khiron Europe, says: "We are glad to see our strong commitment with medical research bear its fruits with this publication.
  • Khiron is a true pioneer in the medical cannabis landscape in the UK, and not just because of its products.
  • Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products.
  • Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable).

Khiron Comments on the Results of Project Twenty21 - UK´s Largest Observational Study into Medical Cannabis Products

Retrieved on: 
Tuesday, May 11, 2021

"\nTejinder Virk, President of Khiron Europe, says: "We are glad to see our strong commitment with medical research bear its fruits with this publication.

Key Points: 
  • "\nTejinder Virk, President of Khiron Europe, says: "We are glad to see our strong commitment with medical research bear its fruits with this publication.
  • Khiron is a true pioneer in the medical cannabis landscape in the UK, and not just because of its products.
  • Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products.
  • Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable).

NEXT SUPER STOCKS on The Move: Tetra Bio-Pharma, Relay Medical, Victory Square Technologies, and Red Light Holland

Retrieved on: 
Friday, May 7, 2021

REDUVO is a synthetic THC-based soft gel capsule indicated in severe nausea and vomiting associated with cancer chemotherapy.

Key Points: 
  • REDUVO is a synthetic THC-based soft gel capsule indicated in severe nausea and vomiting associated with cancer chemotherapy.
  • A highlight of the presentation was a video demo of the company\xe2\x80\x99s rapid testing and tracking platform for infectious diseases, including COVID-19.
  • iMicrodose Packs powered by Red Light Holland are now available in 144% more locations than previously announced.
  • Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K\nAbout Wall Street Reporter\xe2\x80\x99s Next Super Stock conference:\nWall Street Reporter\'s NEXT SUPER STOCK Live!

Holland & Barrett further enhances its CBD portfolio with Elevar Leafs CBD oral strips

Retrieved on: 
Friday, May 7, 2021

These scientifically developed CBD oral strips offer an easier, more discreet and accurate alternative format for CBD intake.

Key Points: 
  • These scientifically developed CBD oral strips offer an easier, more discreet and accurate alternative format for CBD intake.
  • "We are confident the user-friendliness and efficacy of our CBD oral strips will differentiate itself from current assortment of CBD products at H&B, ultimately adding value to their offerings.
  • "\nElevar Leafs CBD Oral Strips are developed using proprietary technologies in a cGMP and FDA-registered facility.
  • The most recent product release includes a CBD Oral Strips line under the brand Elevar Hemp .\n'

Nextleaf Solutions Provides Update on CBD Business

Retrieved on: 
Thursday, May 6, 2021

The bulk distilled CBD oils will be supplied to both the wholesale market and directly to provincially-authorized distributors and retailers across Canada by Labs.

Key Points: 
  • The bulk distilled CBD oils will be supplied to both the wholesale market and directly to provincially-authorized distributors and retailers across Canada by Labs.
  • "The receipt of our sales licence has unlocked new revenue segments and this agreement will offer Nextleaf the opportunity to prove the disruptive nature of our technology.
  • Through its wholly-owned subsidiary Nextleaf Labs Ltd, a licensed processor, the Company is a low-cost producer of cannabis distillate and private label THC & CBD oils.
  • Nextleaf is developing delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing.

Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital

Retrieved on: 
Thursday, May 6, 2021

This first of its kind collaboration will focus on increasing healthcare provider and patient education on medical cannabis products and provide patients with a one stop process for accessing plant-based cannabis for medical use, in coordination with their hospital healthcare team.

Key Points: 
  • This first of its kind collaboration will focus on increasing healthcare provider and patient education on medical cannabis products and provide patients with a one stop process for accessing plant-based cannabis for medical use, in coordination with their hospital healthcare team.
  • Avicanna and Sunnybrook Hospital aim to establish a gold standard of care for cannabinoid-based medicine by providing support and educating and training physicians, pharmacists and patients on the formulary of the RHO Phyto products.
  • The RHO Phyto product line consists of oral, sublingual, and topical delivery systems offered in a range of CBD only and CBD-THC ratios.
  • All RHO Phyto formulations are designed to maintain the stability of the cannabinoids, and provide accurate dosing.

Global Industrial Hemp Market Forecast Report 2021-2026: Breakdown by Textiles, Personal Care, Food & Beverages, Animal Care, Paper, Automotive, Construction Materials, & Furniture - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 5, 2021

Hemp can be grown up as a fibre, seed, or another dual-function crop.

Key Points: 
  • Hemp can be grown up as a fibre, seed, or another dual-function crop.
  • Conversely, Hemp is also from the same species of plant, Cannabis sativa, as marijuana.\nThe dynamic chemical present in the plant is tetrahydrocannabinol (THC).
  • High prices for hemp products are obsessed primarily by the need to produce CBD and increase plant relatives to other crops.
  • This use of Hemp in the advancement of COVID 19 vaccines has increased market demand.\n'

Radient Technologies Announces Strategic Licensing Agreement with HighGrade Supply Ltd.

Retrieved on: 
Wednesday, May 5, 2021

Radient signs exclusive licensing agreement and custom manufacturing agreement to bring to market HighGrade premium concentrates; Radient to launch a custom hydrocarbon extraction platform to bring premium HighGrade branded products into the medicinal and recreational cannabis space

Key Points: 
  • The sales offtake through all channels is expected to be approximately 200 kg of product per month starting July 2021, growing to over 4000 kg per annum from calendar Q1 2022 onwards.
  • Radient expects that demand for high quality premium concentrates based on hydrocarbon extracts will form a core part of the recreational Cannabis 2.0 market in Canada.
  • Radient also has a science lab that is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space.
  • Please visit www.radientinc.com for more information.\nFor further information please contact:\nThis press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation.

Hemp CBD Oil: Technological Advancements Offer Consumers More Choice Through the Continued Refinement and Extraction of THC Variants

Retrieved on: 
Tuesday, May 4, 2021

b'Las Vegas, May 04, 2021 (GLOBE NEWSWIRE) -- There\xe2\x80\x99s no denying that the CBD industry is booming.

Key Points: 
  • b'Las Vegas, May 04, 2021 (GLOBE NEWSWIRE) -- There\xe2\x80\x99s no denying that the CBD industry is booming.
  • This means consumers would either avoid them completely and buy CBD products, or experience them completely and buy THC products.\nNow, with great advancements in THC extraction, variations of hemp CBD oil , gummies, tinctures and more are being created that give consumers a choice of how much \xe2\x80\x98euphoria\xe2\x80\x99 they wish to experience:\nThe hemp industry is experiencing a real shift with the advancement of THC extraction.
  • CBD oil, gummies, distillate and more are now being rivalled by these alternatives that many consumers find more appealing.\nFresh Bros\xe2\x84\xa2 is much more than a licensed CBD and Hemp product manufacturer.
  • They focus on developing transparent, innovative, and reliable products and for high performance individuals, entrepreneurs, and consumers.